Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Van Buchem disease decoded

17.06.2005


Study underscores the importance of non-coding DNA in disease determination



Today a team of scientists provides convincing evidence that the deletion of a large non-coding DNA segment on human chromosome 17 is responsible for Van Buchem disease. This genetic mutation is one of only a few disease-associated mutations discovered to date that alters a long-range transcriptional regulatory element. The study appears online in the journal Genome Research.

"Our study addresses a fundamental issue with regards to the majority of the human genome that is non-coding in nature, and its potential impact on human health," explains Dr. Gabriela Loots, a scientist in the Department of Genome Biology at Lawrence Livermore National Laboratory who headed the study. "Non-coding regions located far away from the genes they regulate are critical for normal gene expression and are capable of leading to dramatic abnormal phenotypes if altered or deleted."


Van Buchem disease is a rare hereditary disorder of the skeletal system that is characterized by progressive osteosclerosis, particularly in the skull and mandible, but also in the clavicles, ribs, and diaphyses of long bones. Consequences of this increased bone mass usually include facial distortions and pinching of cranial nerves, and the increased nerve pressure often leads to deafness and blindness. Onset of the disease generally occurs during childhood and is manifested only in individuals carrying two copies of the mutant allele.

The locus responsible for Van Buchem disease was previously mapped to the short arm of human chromosome 17 near the gene sclerostin (or SOST), whose protein product functions as a negative regulator of bone formation. Mutations in the protein-coding regions of SOST are known to be responsible for sclerosteosis, another genetic disorder with attributes similar to Van Buchem disease. Because SOST was therefore a strong causal candidate for Van Buchem disease, scientists screened the SOST coding sequence for associated mutations, but to no avail.

Recently, however, a large 52-kilobase deletion was identified at a significant distance – approximately 35 kilobases – from the SOST gene in humans. This deletion, although associated perfectly with Van Buchem disease, removed a large non-protein-coding region; thus, its function, if any, in the development of the disease remained unclear.

The current study, which was led by Dr. Loots, was designed to rigorously investigate the underlying molecular mechanism by which this non-coding sequence might ultimately give rise to Van Buchem disease. Her team included researchers from Lawrence Berkeley National Laboratory (Berkeley, CA), the Novartis Institutes for BioMedical Research (Basel, Switzerland), and the DOE Joint Genome Institute (Walnut Creek, CA).

Dr. Loots and her colleagues engineered a human bacterial artificial chromosome (BAC) and generated transgenic mice with and without the 52 kilobases of DNA that are absent in Van Buchem patients. Although SOST was expressed normally in the early mouse embryo from both lines, SOST was dramatically downregulated in adult mice carrying the deletion, when compared to wild-type transgenic mice. These results provided strong evidence that the lack of SOST expression in humans homozygous for the 52-kilobase deletion is caused by a regulatory element – most likely an enhancer – that is located within the 52-kilobase region and that functions in a bone- and age-specific manner.

The team then utilized comparative sequence analyses and transient transfection assays to identify the actual enhancer sequence within the 52-kilobase deletion region that is responsible for SOST regulation. They aligned 140-kilobases of the human SOST region with the orthologous mouse sequence and identified seven evolutionarily conserved regions (ECRs). The seven ECRs were subjected to in vitro transient transfection enhancer analyses, and one of them – a 250-base-pair region named ECR5 – was found to drive expression in osteoblast-like cells.

These results provide a strong causal link between the 52-kilobase deletion and Van Buchem disease in humans. Drs. Michaela Kneissel and Hansjoerg Keller, collaborators on the project from the Novartis Institutes for BioMedical Research in Basel, Switzerland, point out that, in addition to addressing a fundamental problem in genomics, this project has clinical relevance. "Human genetic diseases of the skeleton, such as sclerosteosis and Van Buchem disease, provide a starting point for understanding the modulation of anabolic bone formation, and ultimately have the potential to identify key molecular components that can be used as new therapeutic agents to treat individuals suffering from bone loss disorders," say the researchers.

On an important scientific note, the methodological approaches employed by these researchers in elucidating the basis for Van Buchem disease will be widely applicable and very powerful in the characterization of other distant, cis-acting regulatory elements.

Maria A. Smit | EurekAlert!
Further information:
http://www.cshl.edu

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>